aTyr Pharma, Inc. (ATYR) Tops Q2 EPS by 1c

aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.

You May Also Be Interested In

• RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges
• Gold Coast Mining Corp. Delaware (GCMG) Tops Q2 EPS by 1c
• CytomX Therapeutics (CTMX) PT Lowered to $14 at Guggenheim